HomeNationSerum Institute pauses COVID-19 vaccine trials in India

Serum Institute pauses COVID-19 vaccine trials in India

@the_news_21

Serum Institute of India (SII) on Thursday said it is pausing clinical trials of AstraZeneca Oxford COVID-19 vaccine candidate in the country.

Earlier this week, AstraZeneca said it had paused the trials because of ‘an unexplained illness’ in a participant in the study.

However, SII on Wednesday said it was continuing with the trials and had not faced any issues.

SII’s latest announcement also comes against the backdrop of the central drug regulator DCGI issuing a show-cause notice to SII for not informing it about AstraZeneca pausing the clinical trials of the Oxford vaccine candidate in other countries.

“We are reviewing the situation and pausing India trials till AstraZeneca restarts the trials,” SII said in a statement.

The Pune-based vaccine maker also said it is following instructions of the Drugs Controller General of India (DCGI), it added.

In the show-cause notice, DCGI V G Somani had asked SII as to why the permission granted for conducting phase 2 and 3 clinical trials of the vaccine candidate in the country be not suspended till patient safety is established.

Subscribe to TheNews21

Stay Ahead with Independent Journalism

Investigations, political analysis and major national and global stories delivered directly to your inbox.

Stay Ahead with Independent Journalism

Investigations, political analysis and major national and global stories delivered directly to your inbox.

39 COMMENTS

  1. Solder together the millions delightful momentous on fanduel casino Hawaii – the #1 tangible in dough casino app in America.
    Reach your $1000 WITH IT AGAIN honorarium and modify every relate, хэнд and rotate into legitimate cash rewards.
    Firm payouts, immense jackpots, and day in action – download FanDuel Casino now and start playing like a pro today!

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Must Read

spot_img

@the_news_21

Serum Institute of India (SII) on Thursday said it is pausing clinical trials of AstraZeneca Oxford COVID-19 vaccine candidate in the country.

Earlier this week, AstraZeneca said it had paused the trials because of ‘an unexplained illness’ in a participant in the study.

However, SII on Wednesday said it was continuing with the trials and had not faced any issues.

SII’s latest announcement also comes against the backdrop of the central drug regulator DCGI issuing a show-cause notice to SII for not informing it about AstraZeneca pausing the clinical trials of the Oxford vaccine candidate in other countries.

“We are reviewing the situation and pausing India trials till AstraZeneca restarts the trials,” SII said in a statement.

The Pune-based vaccine maker also said it is following instructions of the Drugs Controller General of India (DCGI), it added.

In the show-cause notice, DCGI V G Somani had asked SII as to why the permission granted for conducting phase 2 and 3 clinical trials of the vaccine candidate in the country be not suspended till patient safety is established.

Html code here! Replace this with any non empty text and that's it.

39 COMMENTS

  1. Solder together the millions delightful momentous on fanduel casino Hawaii – the #1 tangible in dough casino app in America.
    Reach your $1000 WITH IT AGAIN honorarium and modify every relate, хэнд and rotate into legitimate cash rewards.
    Firm payouts, immense jackpots, and day in action – download FanDuel Casino now and start playing like a pro today!

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Must Read

spot_img